AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2018
Jun 8, 2018
35424_dirs_2018-06-08_c2021583-30f9-46ed-a6d1-28a2eff7b918.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-06-06
Reporting Person: Murray Lilian Shackelford (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3524 | Direct |
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Board/Management Information
2026
Feb 6
Capital/Financing Update
2026
Jan 28
Capital/Financing Update
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19